Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma

Uğur Şahin, Ö. Türeci, Georgy Moiseevich Manikhas, Florian Lordick, Andriy Rusyn, Ihor O. Vynnychenko and 12 more

Rank
20 of 3,031
Percentile
top 0.7%
Where
Annals of Oncology, 2021
Citations
385

From the 2021 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.